Young joined William Blair in May 2026 as part of a broader investment in the firm’s equities platform. With 25 years of ...

William Blair initiated research coverage of Vor Biopharma Inc. (VOR $18.04), a clinical-stage biotechnology company ...

William Blair acted as the exclusive financial advisor to Morgan Stanley Capital Partners (MSCP) in connection with the acquisition of The Rapid Group (TRG). The transaction closed on October 15, 2026 ...

William Blair today announced that C.J. Jaskoll has joined the firm as chief technology officer, leading William Blair’s firmwide strategy to leverage artificial intelligence, data analytics, and ...

William Blair initiated research coverage of Midera Food Processing, Inc. (MFP $39.57), a leading provider of further and end-of-line food processing solutions to customers operating in the protein, ...

William Blair initiated research coverage of Marex Group Limited (MRX $71.95), a high-growth diversified specialty brokerage ...

U.S. biopharma entered the third quarter with meaningful momentum, though the market became more selective as the quarter progressed. The XBI reached a five-year high of approximately $170 in August ...

The rapid adoption of GLP-1 medications is reshaping consumer eating behaviors, with new implications for the restaurant industry. According to a 2026 William Blair survey of 300 GLP-1 users, ...

William Blair acted as lead financial advisor to Knox Lane (Knox) in connection with its acquisition of SAGE Integration (SAGE). The transaction closed on September 9, 2026, and highlights William ...

William Blair acted as financial advisor to Blackstone (NYSE: BX) in connection with its pending acquisition of Flow Control Holdings (FCH) from Audax Private Equity. The transaction was announced on ...

William Blair acted as exclusive financial advisor to Orgvue, a portfolio company of One Peak Partners (One Peak) and Morgan Stanley Expansion Capital, in connection with its sale of a majority stake ...

William Blair today announced that Pete Dalrymple will return to the firm as managing director, vice chair of investment banking. Based in Boston, Dalrymple will advise technology clients and work ...